Mink Therapeutics Inc (INKT)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Mink Therapeutics Inc-Aktie (INKT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	15,748% 0.0552	0.000348	0.0135	0.0396	0.078
Operating Expenses	20.09% 3.2387	4.0527	2.7142	2.5423	1.9626
Interest Income/Expense	7.41% -0.025	-0.027	-0.029	-	-
Benefits Costs and Expenses	-	-	2.7802	2.5027	-
Costs And Expenses	20.09% 3.2387	4.0527	2.7802	2.5027	1.9626
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	21.44% -3.1836	-4.0524	-2.7007	-2.5027	-1.8846
Net Interest Income/Expense	15,748% 0.0552	0.000348	0.0135	0.0396	0.078
Interest And Devidend Income	213.13% 0.0302	-0.0267	-0.0155	-	-
Income/Loss From Continuing Operations Before Tax	101.30% 0.0552	-4.2378	-2.7667	-2.4631	0.078
Income/Loss From Continuing Operations After Tax	31.86% -2.8877	-4.2378	-2.7667	-2.4631	-1.8066
Net Income/Loss	31.86% -2.8877	-4.2378	-2.7667	-2.4631	-1.8066
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	11.58% 4.4433	3.982	3.965	-33.34	39.53
Diluted Average Shares	11.58% 4.4433	3.982	3.965	-33.34	39.53
Basic Earnings Per Share	38.68% -0.65	-1.06	-0.70	-2.64	-0.05
Diluted Earnings Per Share	38.68% -0.65	-1.06	-0.70	-2.64	-0.05
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%